Precision oncology startup 4baseCare has raised Rs 128 crore. This funding will expand its genomics labs globally and scale its AI platform...

India has a structural advantage in quantum computing. Its size inherently creates challenging optimisation issues, offering a practical te...

Articul8, a spin-off from Intel, is raising $30-50 million to establish an India-based AI entity focused on traditional knowledge systems l...

As global oncology races toward next-generation therapies, Avammune Therapeutics is betting on affordable, orally administered immunotherap...

Biohub, a venture by Mark Zuckerberg and Priscilla Chan, has launched a protein biology world model. This advanced AI tool aims to speed up...

Amaravati, a new city in Andhra Pradesh, is becoming a hub for quantum computing. A technology park called Quantum Valley is attracting sci...

AI-driven drug discovery firm Isomorphic Labs secured a massive $2.1 billion in Series B funding. This capital will fuel the expansion of t...

Alphabet's AI drug discovery firm, Isomorphic Labs, is reportedly close to securing over $2 billion in new funding, led by Thrive Capital. ...

The Life Sciences & Pharma category at the ET Most Innovative AI Product Awards 2026. Recognises organisations leveraging AI to accelerate ...

Kiran Mazumdar-Shaw has named her niece Claire Mazumdar as successor, setting up a gradual leadership transition at Biocon. A pioneer who b...

The GPT-Rosalind, named after 20th-century British scientist Rosalind Franklin, is designed to support research ⁠across biochemistry, drug ...

Deloitte India has launched a new quantum technology facility at IIT Bombay. This center, named QCoDE, aims to boost quantum adoption for I...

Anthropic acquires startup Coefficient Bio for about $400 million: report

Using advanced AI, Peptris sifts through large data sets to identify and develop potential drug candidates quickly and cost-effectively, re...

For Connexios, this sale of its anti-diabetes molecules to Boehringer Ingelheim is the first out-licensing deal by an Indian life-sciences ...

Connexios, India’s first drug-discovery product startup, has signed its 1st out-licensing deal, marking a milestone for the Indian pharma i...

In 2003, Nadathur Holdings, the venture investing arm of NS Raghavan, made its first investment in Connexios, a small drug discovery startu...